Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter October 20, 2021

Evaluation of the Beckman Coulter Access Procalcitonin Assay: analytical and clinical performance

Hyunji Choi ORCID logo, Ziyoda Tashpulatova, Soo-Young Moon ORCID logo, Junghee Choi, Ji-Young Kim and Sun Min Lee ORCID logo

Corresponding author: Sun Min Lee, MD, Department of Laboratory Medicine, Pusan National University Yangsan Hospital, 20 Geumo-ro, Mulgeum-eup, Yangsan-si, Gyeongsangnam-do 50612, Republic of Korea, Phone: +82 055 360 1878, Fax: +82 055 3601880, E-mail:

Funding source: Beckman Coulter Korea

Award Identifier / Grant number: Not applicable

Acknowledgments

We thank JY Park at Beckman Coulter Korea for providing technical assistance. We also thank the staff of the 24 h unit in the department of laboratory medicine for screening applicable specimens during nights and weekends.

  1. Research funding: This research was supported by Beckman Coulter Korea with a research grant for this investigator–initiated study, as well as all reagents and calibrator standards used in this study.

  2. Author contributions: Z Tashpulatova, JY Kim, and JH Choi contributed to selecting, analyzing, storing, and delivering the specimens. HJ Choi wrote the manuscript and performed statistical analysis. SY Moon contributed to data acquisition and critical revision. SM Lee designed this study, received research funding, and supervised the entire process. All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interest: The funding organization(s) played only a manufacturer’s role in the study – providing information about reagents and educating medical technicians. The researchers claim no conflicts of interest.

  4. Informed consent: Informed consent was obtained from all individuals included in this study.

  5. Ethical approval: This study was approved including the waiver of informed consent by the Institutional Review Board of Pusan National University Yangsan Hospital (No. 04-2019-032).

References

1. Sager, R, Kutz, A, Mueller, B, Schuetz, P. Procalcitonin-guided diagnosis and antibiotic stewardship revisited. BMC Med 2017;15:15. https://doi.org/10.1186/s12916-017-0795-7.Search in Google Scholar

2. Huynh, HH, Bœuf, A, Pfannkuche, J, Schuetz, P, Thelen, M, Nordin, G, et al.. Harmonization status of procalcitonin measurements: what do comparison studies and EQA schemes tell us? Clin Chem Lab Med 2021;59:1610–22. https://doi.org/10.1515/cclm-2021-0566.Search in Google Scholar

3. Lippi, G, Salvagno, GL, Gelati, M, Pucci, M, Lo Cascio, C, Demonte, D, et al.. Two-center comparison of 10 fully-automated commercial procalcitonin (PCT) immunoassays. Clin Chem Lab Med 2019;58:77–84. https://doi.org/10.1515/cclm-2019-0888.Search in Google Scholar

4. Huynh, H-H, Bœuf, A, Vinh, J, Delatour, V, Liu, Q, Chen, Y, et al.. Evaluation of the necessity and the feasibility of the standardization of procalcitonin measurements: activities of IFCC WG-PCT with involvement of all stakeholders. Clin Chim Acta 2021;515:111–21. https://doi.org/10.1016/j.cca.2021.01.004.Search in Google Scholar

5. Chambliss, AB, Hayden, J, Colby, JM. Evaluation of procalcitonin immunoassay concordance near clinical decision points. Clin Chem Lab Med 2019;57:1414–21. https://doi.org/10.1515/cclm-2018-1362.Search in Google Scholar

6. Cho, HW, Kim, SH, Cho, Y, Jeong, SH, Lee, SG. Concordance of three automated procalcitonin immunoassays at medical decision points. Ann Lab Med 2021;41:419–23. https://doi.org/10.3343/alm.2021.41.4.419.Search in Google Scholar

7. Lippi, G, Salvagno, GL, Gelati, M, Pucci, M, Demonte, D, Faggian, D, et al.. Analytical evaluation of the new Beckman Coulter access procalcitonin (PCT) chemiluminescent immunoassay. Diagnostics 2020;10:128. https://doi.org/10.3390/diagnostics10030128.Search in Google Scholar

8. Hamade, B, Huang, DT. Procalcitonin: where are we now? Crit Care Clin 2020;36:23–40. https://doi.org/10.1016/j.ccc.2019.08.003.Search in Google Scholar

9. Wacker, C, Prkno, A, Brunkhorst, FM, Schlattmann, P. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. Lancet Infect Dis 2013;13:426–35. https://doi.org/10.1016/s1473-3099(12)70323-7.Search in Google Scholar

10. Jeong, S, Park, Y, Cho, Y, Kim, H-S. Diagnostic utilities of procalcitonin and C-reactive protein for the prediction of bacteremia determined by blood culture. Clin Chim Acta 2012;413:1731–6. https://doi.org/10.1016/j.cca.2012.06.030.Search in Google Scholar

11. Schuetz, P, Christ-Crain, M, Huber, AR, Müller, B. Long-term stability of procalcitonin in frozen samples and comparison of Kryptor and VIDAS automated immunoassays. Clin Biochem 2010;43:341–4. https://doi.org/10.1016/j.clinbiochem.2009.08.029.Search in Google Scholar

Received: 2021-06-13
Accepted: 2021-10-07
Published Online: 2021-10-20
Published in Print: 2022-01-27

© 2021 Walter de Gruyter GmbH, Berlin/Boston

Scroll Up Arrow